All results

184 results for tests

• ACTIV-4d or Novel Experimental COVID Therapies Affecting Host Response (NECTAR)

  The overarching goal of the Master Protocol is to find effective strategies for inpatient management of patients with COVID-19. Therapeutic goals for patients…

  Ages

  18 Years - N/A

  Sexes

  All

• ADOPT PGx

  This study is comprised of three separate pharmacogenetic trials grouped into a single protocol due to similarities in the intervention, the hypotheses, and…

  Ages

  8 Years - N/A

  Sexes

  All

• AEVI-007

  The main purpose of the study is to evaluate the safety and tolerability of Camoteskimab in participants with Still's Disease. ### Inclusion Criteria: 1.…

  Ages

  18 Years - 75 Years

  Sexes

  All

• AIM2ACT

  The aim is to test the efficacy of AIM2ACT and long-term maintenance of treatment effects in a fully-powered randomized controlled trial with 160 early…

  Ages

  12 Years - 70 Years

  Sexes

  All

• ANCHORS: UH3

  80 young adult men will complete an initial survey and receive 1 of 2 types of alcohol and sexual health education and information to encourage prevention of…

  Ages

  18 Years - 30 Years

  Sexes

  Male

• APL2-C3G-314

  This study is designed as a long-term extension to Study APL2-C3G-310, and is being conducted to establish the long-term safety and efficacy of pegcetacoplan…

  Ages

  12 Years - N/A

  Sexes

  All

• APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)

  The APOLLO study is being done in an attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation based upon…

  Ages

  N/A - N/A

  Sexes

  All

• ARGX-113-2007

  This study's purpose is to measure the treatment response from efgartigimod PH20 SC compared with placebo in participants with Idiopathic Inflammatory Myopathy…

  Ages

  18 Years - N/A

  Sexes

  All

• ATB200-08

  This is a Phase 3, open-label, multicenter study to evaluate the safety, efficacy, PK, PD, and immunogenicity of cipaglucosidase alfa/miglustat treatment in…

  Ages

  N/A - 17 Years

  Sexes

  All

• ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  In parallel with the growth of American Thrombosis and Hemostasis Network's (ATHN) clinical studies, the number of new therapies for all congenital and…

  Ages

  N/A - N/A

  Sexes

  All